Teladoc Health, Inc.

TDOC

US87918A1051

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 18/05/2024 am IST			5-day change	1st Jan Change
12.73 ^USD	-1.32%		+6.53%	-40.93%

29/04	Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating	MT
26/04	UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating	MT

Teladoc Health, Inc. Announces Resignation of Claus T. Jensen, PhD as Chief Innovation Officer Effective December 1, 2023

November 15, 2023 at 02:35 am IST

Teladoc Health, Inc. announced that, on November 8, 2023, Claus T. Jensen, PhD resigned as Chief Innovation Officer of Teladoc Health, Inc., effective December 1, 2023.

Latest news about Teladoc Health, Inc.

Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating	29/04	MT
UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating	26/04	MT
Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating	26/04	MT
Transcript : Teladoc Health, Inc., Q1 2024 Earnings Call, Apr 25, 2024	26/04
Earnings Flash (TDOC) TELADOC HEALTH Reports Q1 Revenue $646.1M, vs. Street Est of $637.4M	26/04	MT
Teladoc Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
Teladoc Health, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024	26/04	CI
Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024	13/04	CI
Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating	08/04	MT
Teladoc Chief Executive Leaves, Chief Financial Officer Mala Murthy Named Acting CEO	05/04	MT
Teladoc Health, Inc. Announces Chief Executive Officer Changes	05/04	CI
Teladoc Health Seeks M&A	13/03	CI
Transcript : Teladoc Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:30 AM	13/03
Sector Update: Health Care Stocks Gain Late Afternoon	08/03	MT
Sector Update: Health Care Stocks Stronger in Afternoon Trading	08/03	MT
Teladoc Expands Obesity, Weight-Management Offering; Shares Rise	07/03	MT
Teladoc Health Insider Sold Shares Worth $266,354, According to a Recent SEC Filing	06/03	MT
Teladoc Health Insider Sold Shares Worth $433,854, According to a Recent SEC Filing	06/03	MT
Transcript : Teladoc Health, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 02:50 PM	05/03
Leerink Partners Initiates Coverage on Teladoc With Market Perform Rating, $17 Price Target	26/02	MT
Deutsche Bank Adjusts Teladoc Price Target to $22 From $23, Maintains Hold Rating	22/02	MT
Health Care Down on a Mixed Growth View -- Health Care Roundup	22/02	DJ
Sector Update: Health Care Stocks Mixed in Late Afternoon	22/02	MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	22/02	MT
Citigroup Adjusts Teladoc Price Target to $19 From $21, Maintains Neutral Rating	21/02	MT

Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.

Sector

Healthcare Facilities & Services

Calendar

23/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Teladoc Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

12.73 USD

Average target price

17.19 USD

Spread / Average Target

+35.04%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Telemedicine Services

	1st Jan change	Capi.
TELADOC HEALTH, INC.	-40.93%	2.16B
QDM INTERNATIONAL INC.	+115.18%	703M
TALKSPACE, INC.	+8.27%	467M
AMERICAN WELL CORPORATION	-67.19%	145M
SHL TELEMEDICINE LTD.	-32.23%	85.06M

Telemedicine Services